ICU
SeaStar Medical Holding Corp
NASDAQ · Healthcare · Biotechnology · US
$3.54
+1.22%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.95
- Revenue estimate
- $500.0K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.91
- EPS estimate
- -$0.97
- Revenue actual
- $615.0K
- Revenue estimate
- $486.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +3.4%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.97 | -$0.91 | Beat 6.19% | $615.0K |
| May 13, 2026 | -$0.73 | -$0.90 | Miss -23.29% | $495.0K |
| Mar 25, 2026 | -$0.97 | -$0.80 | Beat 17.53% | $420.0K |
| Nov 13, 2025 | -$1.50 | -$1.30 | Beat 13.33% | $183.0K |
| Aug 13, 2025 | -$0.43 | -$0.18 | Beat 58.14% | $338.0K |
| Mar 27, 2025 | -$0.89 | -$0.90 | Miss -1.12% | $67.0K |
| Mar 13, 2024 | -$0.13 | -$0.22 | Miss -69.23% | — |
| Nov 14, 2023 | -$0.25 | -$3.00 | Miss -1100.00% | — |
| Aug 14, 2023 | -$0.25 | -$6.25 | Miss -2400.00% | — |
| May 15, 2023 | -$5.00 | -$10 | Miss -100.00% | — |
| Sep 30, 2022 | — | -$36 | — | — |
| Mar 31, 2022 | — | -$19 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026